Floatz logo

Growth Hormone Releasing Hormone 1-44

Growth Hormone Deficiency

Massachusetts General Hospitalprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Growth Hormone Deficiency cohort.

Asset / SponsorPhaseRating
Genotropin
University of Calgary
Phase 4BBB
Omnitrope
University Hospital, Toulouse
Phase 4BB
Tesamorelin
Columbia University
Phase 4B
ADVICOR COMPONENT NIACIN
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 1/2CCC
Recombinant Gh Saizen
Federico II University
Phase 3NR

Same molecule, other indications

Growth Hormone Releasing Hormone 1-44 is also rated in:

Abdominal ObesityDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →